The development and application of a monoclonal antibody purification platform: a purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies

MLA

Glynn, Judy, et al. “The Development and Application of a Monoclonal Antibody Purification Platform: A Purification Scheme to Maximize the Efficiency of the Purification Process and Product Purity While Minimizing the Development Time for Early-Phase Therapeutic Antibodies.” Biopharm International, vol. 22, no. 3, Mar. 2009, p. S16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.197926269&authtype=sso&custid=ns315887.

APA

Glynn, J., Hagerty, T., Pabst, T., Annathur, G., Thomas, K., Johnson, P., Ramasubramanyan, N., & Mensah, P. (2009, March 1). The development and application of a monoclonal antibody purification platform: a purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies. Biopharm International, 22(3), S16.

Chicago

Glynn, Judy, Timothy Hagerty, Timothy Pabst, Gopinath Annathur, Kristin Thomas, Paul Johnson, Natarajan Ramasubramanyan, and Paul Mensah. 2009. “The Development and Application of a Monoclonal Antibody Purification Platform: A Purification Scheme to Maximize the Efficiency of the Purification Process and Product Purity While Minimizing the Development Time for Early-Phase Therapeutic Antibodies.” Biopharm International, March 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.197926269&authtype=sso&custid=ns315887.